ArticleHuman vaccines & immunotherapeutics2025
Awareness and vaccination willingness of middle-aged and elderly individuals in Southwest China toward to herpes zoster vaccine.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Herpes zoster vaccination among older adults in urban China: A mixed-methods study in Shenzhen.Human vaccines & immunotherapeutics · 2026Article
- Factors Associated with Prescription-to-Vaccination Conversion and Timeliness: A Real-World Analysis.Vaccines · 2026Article
- Improving Vaccine Knowledge Among Adolescents: A Pre-Post School-Based Educational Intervention in Southern Italy.Vaccines · 2026Article
- Herpes zoster as a diagnostic pitfall leading to an unwarranted cholecystectomy: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of herpes zoster is increasing in China's aging society, and vaccination is the most effective preventive measure. However, vaccine hesitancy is a major obstacle. A survey was conducted among individuals aged 50 and above in Southwest China to assess their awareness and willingness to vaccinate against herpes zoster. The 3C model was used to analyze factors influencing vaccine hesitancy. Among 3,007 participants, vaccine hesitancy ranged from 62.7% to 68.9% across different regions, and 62.5% to 64.7% had no knowledge of the herpes zoster vaccine. Statistical analysis showed that higher disposable income, better knowledge of herpes zoster and the vaccine were associated with lower vaccine hesitancy. According to the 3C model, lower confidence in vaccines, higher complacency, and perceived inconvenience of vaccination were linked to increased hesitancy. This study found low awareness and willingness to vaccinate among middle-aged and older adults in Southwest China. It provided insights into the causes of vaccine hesitancy, which could inform the development of effective vaccination strategies to reduce herpes zoster incidence in the elderly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.